Grifols Buys Talecris to Increase US Share in Plasma Protein Therapies
By Debbie Tranter
Pharma Deals Review: Vol 2010 Issue 6 (Table of Contents)
Published: 18 Jun-2010
DOI: 10.3833/pdr.v2010.i6.1354 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Grifols SA, European major player in blood plasma products acquires Talecris Biotherapeutics for USD 3 B to expand its share in the US market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS